ArticleFrontiers in pharmacology2026
Deciphering tuberculosis pathway mechanisms via graph neural networks and multimodal deep learning: a comprehensive AI-driven framework for precision medicine.
Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Tuberculosis (TB) remains a global health crisis, with complex molecular mechanisms that are not fully understood. Traditional pathway analysis methods fail to capture the intricate non-linear relationships within biological networks. Methods: We developed a novel artificial intelligence framework integrating graph neural networks (GNNs), transformer architectures, and multimodal deep learning to decipher TB pathway mechanisms. Our approach constructs a comprehensive pathway-gene interaction network from three critical pathways (Tuberculosis hsa05152, Antigen processing hsa04612, and NF-κB signaling hsa04064) and employs three interconnected models: (1) a Graph Convolutional Network for learning pathway-gene relationships, (2) a Transformer encoder for pathway activity prediction, and (3) a multimodal fusion model with attention mechanisms integrating transcriptomic, pathway, and clinical data. The framework was trained and validated on 467 clinical samples and 529 transcriptomic samples from five GEO datasets. Results: The Transformer model achieved strong performance in pathway activity prediction ( Conclusion: This study represents the first comprehensive application of GNNs and multimodal deep learning to TB pathway analysis. Our framework provides novel insights into TB pathogenesis, identifies potential therapeutic targets, and demonstrates the power of AI-driven approaches for understanding complex disease mechanisms. The interpretability of our models through attention mechanisms enables translation of computational findings into actionable biological insights, with significant implications for precision medicine and personalized TB treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.